Latest Screening Stories

Accurate, Rapid, Cost-Effective Blood Test Aims to Confirm True Negative Findings While Halving the Rate of False Negative Mammography Results MIAMI, May 2, 2013 /PRNewswire/ -- Eventus Diagnostics, Inc. (EventusDx) today announced that it has received CE mark designation for its Octava Pink(TM) breast cancer test intended for confirmatory use in women who have received negative mammography results. The National Cancer Institute (NCI) estimates that screening mammograms miss about...

Screening rates increase even more when doctors discuss details of screening tests, Kaiser Permanente study finds PORTLAND, Ore., April 29, 2013 /PRNewswire/ -- Patients who visited their doctor for any reason were nearly six times more likely to get screened for colon cancer compared to those who didn't visit their doctor, according to a study funded by the National Cancer Institute and published online today in the American Journal of Managed Care. The study was conducted in an...

NEW YORK, April 29, 2013 /PRNewswire-USNewswire/ -- Who would have ever thought that sequestration and budget battles would determine whether a precious newborn baby would survive? How is it possible that a "continuing resolution" could actually deprive a newborn baby of "continuing" his or her life? It is exactly what has happened to our innocent newborns, who are victimized by government officials that are dealing with partisan politics and divisiveness. To view the multimedia...

Researchers at the University of Cincinnati have found that targeted screening for populations with a higher estimated prevalence for hepatitis C may be cost-effective. These findings, published in the April 24, 2013, online edition of the journal Clinical Infectious Diseases, indicate that targeted screening for chronic hepatitis C virus infection is cost-effective when the prevalence of hepatitis C in a population exceeds 0.84 percent (84/10,000). The study further demonstrates how a...

In 2009, the United States Preventative Services Task Force recommended against annual mammograms for women between the ages of 40 and 49 More than three years after the United States Preventive Services Task Force (USPSTF) recommended against routine mammogram screening for women between the ages of 40 and 49, a study from Brigham and Women's Hospital (BWH) finds that mammogram rates in the United States have not declined in that age group, or any other. The study results are published in...

One view 3D breast screening (tomosynthesis) means less radiation dose and about five seconds less compression, but a study from Yale University, New Haven, CT, found that obtaining both views is necessary to help ensure that a cancer won't be missed. There are practices in Europe that have reported performing only a single view, specifically the mediolateral oblique (MLO) view, said Dr. Noa Beck, the lead author of the study. Two views are standard in the U.S. for 3D breast screening; "we...

Screening breast ultrasound performed after mammography on women with greater than 50% breast density detects an additional 3.4 cancers or high risk lesions per one thousand woman screened, a detection rate just under that of screening mammography alone for women with less dense breasts, a new study shows. Screening mammography detects 4-5 cancers per thousand women screened. The study, conducted in conjunction with seven Connecticut radiology practices, included 19,745 women who had dense...

A new design of screening could improve ratio between benefit and harms of screening Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today on bmj.com. Prostate specific antigen (PSA) screening is widely used for the early detection of prostate cancer, but remains highly controversial, as it became widespread long before evidence to prove its value....

Breast cancer screening with tomosynthesis finds cancers missed by 2D screening alone utilizing the double read with arbitration approach used in many countries of the world BEDFORD, Mass., April 16, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that a new study published...

Outcome calls into question the costs of CAD-enhanced mammography A costly and widely used mammography add-on increases detection of noninvasive and early-stage invasive breast cancer but also makes more mistakes than mammography alone, researchers from UC Davis and the University of Washington have found. Published in the April 16 issue of the Annals of Internal Medicine, the study of women enrolled in Medicare is the largest comparison of clinical outcomes of routine screening...